Search

Search results

2 results found

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.

Hundertmark, Moritz J, Sarah M Birkhoelzer, Clara Portwood, Adrienne G Siu, Violet Matthews, Andrew J Lewis, James Grist, et al. 2026. “IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes.”. Circulation 153 (8): 550-63.